Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ: AUPH · Real-Time Price · USD
16.65
+0.43 (2.65%)
At close: Oct 9, 2026, 4:00 PM EDT
16.71
+0.06 (0.37%)
After-hours: Oct 9, 2026, 7:30 PM EDT
Aurinia Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, Aurinia Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $17.86. The average 1-year stock price forecast is 7.27% higher than the current stock price, while the lowest is $16 (-3.90%) and the highest is $21 (+26.13%).
Price Target: $17.86 (+7.27%)
Analyst Consensus: Buy
Price Target
Chart* Price targets were last updated on Aug 20, 2026.
Analyst Ratings
The average analyst rating for Aurinia Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 5 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 3 | 3 | 3 | 3 | 3 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bloom Burton | Bloom Burton | Buy Upgrades $15 → $21 | Buy | Upgrades | $15 → $21 | +26.13% | Aug 20, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $17 | Buy | Maintains | $17 | +2.10% | Aug 20, 2026 |
| RBC Capital | RBC Capital | Hold Maintains $15 → $16 | Hold | Maintains | $15 → $16 | -3.90% | Aug 7, 2026 |
Financial Forecast
Revenue This Year
327.88M
from 283.06M
Increased by 15.83%
Revenue Next Year
397.70M
from 327.88M
Increased by 21.30%
EPS This Year
0.94
from 2.07
Decreased by -54.40%
EPS Next Year
1.07
from 0.94
Increased by 12.99%
EPS and Forward PE are based on non-GAAP adjusted numbers.